tiprankstipranks
Advertisement
Advertisement

Nanollose Loss Widens as Pre-Revenue Development Phase Continues

Story Highlights
Nanollose Loss Widens as Pre-Revenue Development Phase Continues

Claim 30% Off TipRanks

Nanollose Ltd. ( (AU:NC6) ) has issued an announcement.

Nanollose Limited reported a sharp widening of its half-year loss to $1,526,079 for the period ended 31 December 2025, more than doubling the prior corresponding period’s loss of $725,681, while revenue from ordinary activities remained at zero. The company’s net tangible liabilities improved to $169,751 from $573,932 a year earlier, but with no dividends declared and an expanded share base, the figures highlight ongoing investment and cash burn as Nanollose continues to develop its technology platform without yet generating operating income.

The half-year report, which has been reviewed by auditors, underscores the early-stage nature of Nanollose’s operations and the financial risks typical for pre-revenue technology developers in the sustainable materials sector. Shareholders face continued dilution, reflected in the increase in shares on issue to 325,346,420 and a negative net tangible asset backing per share of 0.05 cents, suggesting that near-term returns will likely depend on the company’s ability to convert its R&D efforts into commercial partnerships or product revenues.

The most recent analyst rating on (AU:NC6) stock is a Sell with a A$0.07 price target. To see the full list of analyst forecasts on Nanollose Ltd. stock, see the AU:NC6 Stock Forecast page.

More about Nanollose Ltd.

Nanollose Limited is an Australia-based company focused on developing and commercialising sustainable, plant-free cellulose technologies for use in textiles and related materials. The company targets industries seeking environmentally friendly alternatives to traditional fibre and fabric inputs, positioning itself in the emerging market for next-generation biomaterials.

Average Trading Volume: 154,778

Technical Sentiment Signal: Strong Buy

Current Market Cap: A$22.2M

For an in-depth examination of NC6 stock, go to TipRanks’ Overview page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1